ICU Retained Earnings Total Equity from 2010 to 2024

ICUI Stock  USD 167.81  0.65  0.39%   
ICU Medical's Retained Earnings Total Equity is increasing with slightly volatile movements from year to year. Retained Earnings Total Equity is predicted to flatten to about 553.4 M. Retained Earnings Total Equity is the portion of total equity that consists of earnings retained by the company, reinvested in its core business or used to pay debt. View All Fundamentals
 
Retained Earnings Total Equity  
First Reported
2009-03-31
Previous Quarter
827.7 M
Current Value
817.8 M
Quarterly Volatility
226.3 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check ICU Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ICU Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 263.2 M, Interest Expense of 107.9 M or Total Revenue of 2.4 B, as well as many indicators such as Price To Sales Ratio of 1.01, Dividend Yield of 0.0 or PTB Ratio of 1.08. ICU financial statements analysis is a perfect complement when working with ICU Medical Valuation or Volatility modules.
  
Check out the analysis of ICU Medical Correlation against competitors.
For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.

Latest ICU Medical's Retained Earnings Total Equity Growth Pattern

Below is the plot of the Retained Earnings Total Equity of ICU Medical over the last few years. It is the portion of total equity that consists of earnings retained by the company, reinvested in its core business or used to pay debt. ICU Medical's Retained Earnings Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ICU Medical's overall financial position and show how it may be relating to other accounts over time.
Retained Earnings Total Equity10 Years Trend
Slightly volatile
   Retained Earnings Total Equity   
       Timeline  

ICU Retained Earnings Total Equity Regression Statistics

Arithmetic Mean586,375,460
Geometric Mean536,637,164
Coefficient Of Variation42.28
Mean Deviation200,674,305
Median553,438,854
Standard Deviation247,917,388
Sample Variance61463T
Range820.7M
R-Value0.87
Mean Square Error15610.2T
R-Squared0.76
Significance0.00002
Slope48,460,230
Total Sum of Squares860482.4T

ICU Retained Earnings Total Equity History

2024553.4 M
2023B
2021911.8 M
2020808.7 M
2019721.8 M
2018620.7 M
2017585.6 M

About ICU Medical Financial Statements

Investors use fundamental indicators, such as ICU Medical's Retained Earnings Total Equity, to determine how well the company is positioned to perform in the future. Although ICU Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Retained Earnings Total EquityB553.4 M

Currently Active Assets on Macroaxis

When determining whether ICU Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ICU Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Icu Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Icu Medical Stock:
Check out the analysis of ICU Medical Correlation against competitors.
For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICU Medical. If investors know ICU will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICU Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.24)
Earnings Share
(4.57)
Revenue Per Share
96.302
Quarterly Revenue Growth
0.065
Return On Assets
0.0066
The market value of ICU Medical is measured differently than its book value, which is the value of ICU that is recorded on the company's balance sheet. Investors also form their own opinion of ICU Medical's value that differs from its market value or its book value, called intrinsic value, which is ICU Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICU Medical's market value can be influenced by many factors that don't directly affect ICU Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICU Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICU Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICU Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.